{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:29:23Z","timestamp":1787689763812,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtauto.2024.100231","type":"journal-article","created":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T01:01:41Z","timestamp":1704589301000},"page":"100231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluating the inhibition of IL-17A and TNF\u03b1 in a cartilage explant model cultured with Th17-derived cytokines"],"prefix":"10.1016","volume":"8","author":[{"given":"Solveig Skovlund","family":"Groen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-9297","authenticated-orcid":false,"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-1417","authenticated-orcid":false,"given":"Christian S.","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten H.","family":"Dziegiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-4749","authenticated-orcid":false,"given":"Marie","family":"Skougaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-300X","authenticated-orcid":false,"given":"Simon Francis","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Holm","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2024.100231_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00606","article-title":"Distinct in vitro T-helper 17 differentiation capacity of peripheral naive T cells in rheumatoid and psoriatic arthritis","volume":"9","author":"Baricza","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2024.100231_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210305","article-title":"Pathogenic role of IL-17 and therapeutic targeting of IL-17F in psoriatic arthritis and spondyloarthropathies","volume":"24","author":"S\u00e1nchez-Rodr\u00edguez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2024.100231_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2024.100231_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis \u2014 results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2024.100231_bib5","first-page":"890","article-title":"Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study","volume":"77","author":"Mease","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2024.100231_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17a in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2024.100231_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2024.100231_bib8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17a inhibitor, in ankylosing spondylitis, N","volume":"373","author":"Baeten","year":"2015","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.jtauto.2024.100231_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2024.100231_bib10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0140-6736(17)31429-0","article-title":"Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial","volume":"389","author":"Nash","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jtauto.2024.100231_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"Mease","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2022","key":"10.1016\/j.jtauto.2024.100231_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"186","author":"Schett","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100231_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/ar3238","article-title":"Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis","volume":"13","author":"Ito","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2024.100231_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/eji.202048773","article-title":"Th17 lymphocyte\u2010dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab","volume":"51","author":"Margheri","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2024.100231_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cellsig.2003.09.008","article-title":"Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes","volume":"16","author":"Sylvester","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jtauto.2024.100231_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/ar2772","article-title":"Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-\u03b1, Oncostatin M and response to biologic therapies","volume":"11","author":"Moran","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2024.100231_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.61.8.704","article-title":"Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines","volume":"61","author":"Koshy","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2024.100231_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cyto.2011.08.015","article-title":"Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes","volume":"56","author":"Tanigawa","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.jtauto.2024.100231_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: from discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jtauto.2024.100231_bib20","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1016\/j.ocarto.2022.100292","article-title":"Dynamic compression inhibits cytokine-mediated type II collagen degradation","volume":"4","author":"Engstr\u00f8m","year":"2022","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.jtauto.2024.100231_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2021.100207","article-title":"A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritis","volume":"3","author":"Groen","year":"2021","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.jtauto.2024.100231_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21175992","article-title":"The anti-ADAMTS-5 nanobody\u00ae M6495 protects cartilage degradation ex vivo","volume":"21","author":"Siebuhr","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2024.100231_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-020-00122-x","article-title":"Characterization of the interleukin-17 effect on articular cartilage in a translational model: an explorative study","volume":"4","author":"Sinkeviciute","year":"2020","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100231_bib24","doi-asserted-by":"crossref","first-page":"12347","DOI":"10.3390\/s120912347","article-title":"Multiple applications of alamar blue as an indicator of metabolic function and cellular health in cell viability bioassays","volume":"12","author":"Rampersad","year":"2012","journal-title":"Sensors"},{"key":"10.1016\/j.jtauto.2024.100231_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","article-title":"Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-Increased serum CIIM in subjects with severe radiographic osteoarthritis","volume":"44","author":"Bay-Jensen","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jtauto.2024.100231_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-2-259","article-title":"Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments","volume":"2","author":"Wang","year":"2009","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jtauto.2024.100231_bib27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2016.07.108","article-title":"Quantification of fibronectin as a method to assess ex vivo extracellular matrix remodeling","volume":"478","author":"Bager","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jtauto.2024.100231_bib28","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.3390\/ijms151018789","article-title":"Cartilage turnover reflected by metabolic processing of type II collagen: a novel marker of anabolic function in chondrocytes","volume":"15","author":"Gudmann","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2024.100231_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human TH-17 cells requires transforming growth factor-\u03b2 and induction of the nuclear receptor ROR\u03b3t","volume":"9","author":"Manel","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2024.100231_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-\u03b2 are required for differentiation of human T H17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2024.100231_bib31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2024.100231_bib32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/s10165-012-0811-x","article-title":"The roles of IFN-\u03b3 versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts","volume":"23","author":"Kato","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100231_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005087","article-title":"CD28 co-stimulation down regulates Th17 development","volume":"4","author":"Bouguermouh","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2024.100231_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52562-2","article-title":"Expansion, isolation and first characterization of bovine Th17 lymphocytes","volume":"9","author":"Cunha","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2024.100231_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.immuni.2020.06.022","article-title":"The cytokine IL-17a limits Th17 pathogenicity via a negative feedback loop driven by autocrine induction of IL-24","volume":"53","author":"Chong","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2024.100231_bib36","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2024.100231_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015038","article-title":"Maturation-dependent licensing of naive T cells for rapid TNF production","volume":"5","author":"Priyadharshini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2024.100231_bib38","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2024.100231_bib39","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2024.100231_bib40","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2024.100231_bib41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2024.100231_bib42","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2024.100231_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2021.03.008","article-title":"The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design","volume":"54","author":"Saxton","year":"2021","journal-title":"Immunity"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909024000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909024000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T16:07:34Z","timestamp":1730995654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909024000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"alternative-id":["S2589909024000017"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100231","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the inhibition of IL-17A and TNF\u03b1 in a cartilage explant model cultured with Th17-derived cytokines","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100231"}}